Introduction {#section1-2333392817734523}
============

Substance use disorders (SUDs) are underidentified and undertreated.^[@bibr1-2333392817734523]^ Primary care practices---community health clinics (CHCs) in particular---are opportune settings in which to provide SUD treatment. Most individuals in the United States visit a primary care provider at least annually.^[@bibr2-2333392817734523]^ As SUDs are frequently comorbid with other medical conditions, the prevalence of alcohol and illicit drug use is higher among primary care patients than the general population.^[@bibr3-2333392817734523],[@bibr4-2333392817734523]^ With regard to CHCs, expanded health insurance coverage under the Patient Protection and Affordable Care Act has substantially increased the number of individuals seeking medical care in these settings.^[@bibr5-2333392817734523],[@bibr6-2333392817734523]^ Increased identification and treatment of SUDs in CHCs could address the unmet need among millions of individuals who never receive treatment.^[@bibr1-2333392817734523]^ Screening is particularly important, as identification of substance misuse is often the first step to obtaining treatment. However, little is known about the prevalence and characteristics of patients who screen positive for substance misuse in CHCs. Such information can inform health-care providers and policy makers about the characteristics of individuals who may need SUD care in CHCs to prepare to deliver appropriate levels of care and to establish criteria for determining which patients may need higher levels of care in specialty care settings.

This study compares the characteristics of individuals identified with opioid or alcohol misuse (or both) in a large urban federally qualified health center (FQHC). We focus on opioids and alcohol in this study because there are Food and Drug Administration (FDA)-approved medications appropriate for treating patients with opioid or alcohol use disorders (OAUDs) in primary care settings.^[@bibr7-2333392817734523]^

Methods {#section2-2333392817734523}
=======

Research Procedures {#section3-2333392817734523}
-------------------

This study was part of a larger study of integration of medication-assisted and behavioral treatment for OAUDs into a CHC.^[@bibr7-2333392817734523]^ The study was conducted at a multisite FQHC in Los Angeles County between June 3, 2014, and January 15, 2016, and was approved by the RAND Human Subjects Protection Committee. Medical assistants screened all adult patients for substance misuse with a modified version of the National Institute on Drug Abuse (NIDA) quick screen.^[@bibr8-2333392817734523]^ Patients were considered to have substance misuse if they reported (1) having ≥5 drinks/day (men) or ≥4 drinks/day (women) at least once a month in the past 3 months, (2) taking prescription opioid medication differently than directed by a doctor at least once per month in the past 3 months, or (3) using street drugs, such as heroin, powder cocaine, crack cocaine, methamphetamine, or ecstasy at least once a month in the past 3 months. Patients who screened positive were invited to participate in a more detailed assessment administered by research staff.

Measures {#section4-2333392817734523}
--------

Information was collected on gender, age, race, ethnicity, and current participation in substance use treatment. The presence of serious mental illness was assessed via self-reported diagnosis and/or hospitalization for bipolar, schizophrenia, or schizoaffective disorder with current marked functional impairment. Marked impairment was defined as a score of 7 to 10 on the Sheehan Disability Scale.^[@bibr9-2333392817734523]^ Diagnosis and severity of substance use disorder were assessed with the NIDA-modified version of the World Health Organization's Alcohol, Smoking and Substance Involvement Screening Test version 3.1.^[@bibr8-2333392817734523],[@bibr10-2333392817734523]^ Separate severity scores were calculated for alcohol, prescription opioids, and heroin. For alcohol, patients with scores between 11 and 26 were considered to have moderate use or abuse; for prescription opioids and heroin, patients with scores between 4 and 26 were considered to have moderate use or abuse. Patients with a score of 27 or higher for any substance were considered to have substance dependence.^[@bibr10-2333392817734523]^ In this article, we refer to abuse or dependence as a disorder.^[@bibr11-2333392817734523]^ Because FDA-approved medications are only available for OAUDs, which can be delivered in a CHC, only patients with an OAUD were included in these analyses. Select demographic characteristics (age, gender, and ethnicity) and medical history (diagnoses of bipolar, schizophrenia, and SUDs) of adult patients during the study period were obtained from the clinic's administrative database.

Statistical Analyses {#section5-2333392817734523}
--------------------

We use χ^2^ tests to compare the characteristics of those who screened positive for alcohol, heroin, or prescription opioid misuse to those of all adult patients who visited the FQHC during the study period. Next, we stratified screen-positive individuals into 4 mutually exclusive groups: (1) probable alcohol use disorder (AUD) without opioid use disorder (OUD; heroin or prescription opioid) comorbidity, (2) probable heroin use disorder, (3) probable prescription (Rx) OUD with or without a comorbid AUD, and (4) no probable OAUD diagnosis. We separated these groups because of potentially different care needs and comorbidities of each. Most (85%) individuals with a probable Rx OUD also had an AUD, so we combined them into 1 group. We compared the characteristics of the 4 groups using χ^2^ tests. All analyses were conducted using SAS version 9.3.

Results {#section6-2333392817734523}
=======

During the study period, 15 723 adults visited the FQHC. Based on a sample of weekly screening audits, 94% to 98% of the visits were screened (N = 15 000) by the medical assistants, 4% to 6% of patients screened were eligible for referral, and 745 had substance misuse and were referred for an additional assessment. Fewer than 2% of those eligible for referral refused. Seven hundred thirty-three patients completed the additional assessment.

As shown in [Table 1](#table1-2333392817734523){ref-type="table"}, compared to the clinic population, individuals with a positive screen were more likely to be male (77% vs 44%; *P* \< .0001), younger, less likely to be of Hispanic origin (29% vs 48%; *P* \< .0001), and more likely to have ever been diagnosed with bipolar disorder (32% vs 10%; *P* \< .0001) or schizophrenia (13% vs 1%; *P* \< .0001). Note that while we report race data for both the clinic and the study population, we did not perform a statistical comparison due to the lack of clinic data on individuals identifying with multiple races, a category endorsed by 12.7% of study participants.

###### 

Patient Demographic, Substance Use, and Mental Health Characteristics (N = 733) for the Study Sample, as well as All Patients Aged 18 Years and Over With a Daytime Primary Care Visit to the Clinic Between June 3, 2014, and January 1, 2016.

![](10.1177_2333392817734523-table1)

  Characteristic                                                  Clinic Population   Study Sample   *P*          
  --------------------------------------------------------------- ------------------- -------------- ----- ------ ---------
  All                                                             15723               100            733   100    
  Identify as male                                                6834                43.5           564   76.9   \<.0001
  Age, years                                                                                                      \<.0001
   18-39                                                          5649                35.9           290   39.6   
   40-59                                                          7418                47.2           398   54.3   
   60 and older                                                   2656                16.9           45    6.1    
  Hispanic                                                        7589                48.3           213   29.1   \<.0001
  Race^a^                                                                                                         
   White                                                          13021               82.8           326   44.5   
   African American                                               1836                11.7           97    13.2   
   American Indian/Alaska Native                                  41                  0.3            12    1.6    
  Native Hawaiian/Pacific                                                                                         
   Islander                                                       0                   0.0            3     0.4    
   Asian                                                          621                 3.9            5     0.7    
   Other race                                                     204                 1.3            196   26.7   
   Multiple races                                                 0                   0.0            93    12.7   
  Ever been diagnosed with                                                                                        
   Bipolar disorder                                               1504                9.6            234   31.9   \<.0001
   Schizophrenic or schizoaffective disorder                      205                 1.3            97    13.2   \<.0001
  Has an OAUD (abuse or dependence)                                                                               
    Any-alcohol, prescription opioids, or heroin^b^               617                 3.9            636   86.8   
    Alcohol                                                       521                 3.3            576   78.6   
    Prescription opioids                                          104                 0.7            228   31.1   
    Heroin                                                        ^c^                 ^c^            173   23.6   
    Two substances                                                ^c^                 ^c^            230   31.4   
    All 3 substances                                              ^c^                 ^c^            111   15.1   
  Currently receiving treatment for a substance use disorder^d^   ^c^                 ^c^            47    7.4    
  Has mental health diagnosis that markedly disrupts                                                              
    Work or other daily activities                                ^c^                 ^c^            163   22.2   
    Social activities                                             ^c^                 ^c^            152   20.7   
    Ability to care for house, family, or self                    ^c^                 ^c^            134   18.3   
    At least 1 area of life: work, social activities, self-care   ^c^                 ^c^            194   26.5   
    All 3 areas                                                   ^c^                 ^c^            103   14.1   

Abbreviation: OAUD, opioid or alcohol use disorders.

^a^A comparison of race is not possible because of limits to the reporting software at the clinic.

^b^Clinic numbers only contain information on alcohol and prescription opioid use; information on heroin use disorder unavailable.

^c^Clinic-wide data unavailable.

^d^n = 636, limited to those with any alcohol or opioid misuse based on screener.

Eighty-seven percent of patients with a positive screen for alcohol or opioid misuse had an abuse or dependence diagnosis for either alcohol or opioids; 31% were comorbid for 2 or more substances; and 15% were comorbid for all 3 substances. Twenty-seven percent of the sample reported a past diagnosis of bipolar disorder or schizophrenia along with marked disruption in functioning. Over 90% were not currently receiving SUD treatment.

As shown in [Table 2](#table2-2333392817734523){ref-type="table"}, all diagnostic groups were predominantly male, with the any heroin group having the highest proportion of males (86%). The any heroin group had the greatest proportion of patients in the 18 to 39 age range. Patients in the prescription opioid and heroin groups had higher rates of past bipolar disorder and consequences of mental health conditions than those in the alcohol only or no diagnosis groups (*P* \< .0001).

###### 

Patient Demographics, Substance Use, and Mental Health Characteristics by Diagnosis Group.^a^

![](10.1177_2333392817734523-table2)

  Characteristic                                         No Probable OAUD Diagnosis, n = 97   Probable AUD Only, n = 363   Probable Heroin Use Disorder, With or Without AUD or Rx OUD, n = 173   Probable Rx OUD (With or Without AUD), n = 100   χ^2^, *P* Value                         
  ------------------------------------------------------ ------------------------------------ ---------------------------- ---------------------------------------------------------------------- ------------------------------------------------ ----------------- ------- ----- ------- ---------
  Identify as male                                       66                                   68.0                         267                                                                    73.6                                             149               86.1    82    82.0    .0013
  Age, years                                                                                                                                                                                                                                                                               .0003
   18-39                                                 46                                   47.4                         119                                                                    32.8                                             91                52.6    34    34.0    
   40-59                                                 43                                   44.3                         220                                                                    60.6                                             74                42.8    61    61.0    
   60 and older                                          8                                    8.2                          24                                                                     6.6                                              8                 4.6     5     5.0     
  Hispanic                                               33                                   34.0                         117                                                                    32.2                                             43                24.9    20    20.0    .0360
  Race                                                                                                                                                                                                                                                                                     .1178
   White                                                 34                                   35.1                         159                                                                    43.8                                             92                53.2    41    41.0    
   African American                                      15                                   15.5                         53                                                                     14.6                                             12                6.9     17    17.0    
  American Indian/Alaska                                                                                                                                                                                                                                                                   
   Native                                                1                                    1.0                          7                                                                      1.9                                              1                 0.6     3     3.0     
   Native Hawaiian/Pacific Islander                      1                                    1.0                          1                                                                      0.3                                              1                 0.6     0     0.0     
   Asian                                                 0                                    0.0                          2                                                                      0.6                                              1                 0.6     2     2.0     
   Other race                                            32                                   33.0                         97                                                                     26.7                                             47                27.2    20    20.0    
   Multiple races                                        14                                   14.4                         44                                                                     12.1                                             19                11.0    17    17.0    
  Ever been diagnosed with                                                                                                                                                                                                                                                                 
   Bipolar disorder                                      17                                   17.5                         99                                                                     27.3                                             70                40.5    48    48.0    \<.0001
   Schizophrenic or schizoaffective disorder             12                                   12.4                         32                                                                     8.8                                              30                17.3    23    23.0    .0007
  Has a substance use disorder (abuse or dependence)                                                                                                                                                                                                                                       
   Alcohol                                                                                                                 363                                                                    100.0                                            130               75.1    83    83.0    
   Prescription opioids                                                                                                    0                                                                      0.0                                              128               74.0    100   100.0   
   Heroin                                                                                                                  0                                                                      0.0                                              173               100.0   0     0.0     
   Two substances                                                                                                          0                                                                      0.0                                              147               85.0    83    83.0    
   Currently receiving treatment for an SUD^b^           5                                    5.2                          12                                                                     3.3                                              19                11.0    11    11.0    .0014
  Has a mental health diagnosis that markedly disrupts                                                                                                                                                                                                                                     
   Work or other daily activities                        10                                   10.3                         63                                                                     17.4                                             55                31.8    35    35.0    \<.0001
   Social activities                                     11                                   11.3                         58                                                                     16.0                                             48                27.7    35    35.0    \<.0001
   Ability to care for house, family, or self            7                                    7.2                          55                                                                     15.2                                             45                26.0    27    27.0    \<.0001
   At least 1 area of life                               13                                   13.4                         80                                                                     22.0                                             60                34.7    42    42.0    \<.0001
   All 3 areas                                           6                                    6.2                          37                                                                     10.2                                             40                23.1    20    20.0    \<.0001

Abbreviations: AUD, alcohol use disorder; OUD, opioid use disorder; OAUD, opioid or alcohol use disorder; SUD, substance use disorder.

^a^N = 733.

^b^Individuals in the "no OAUD diagnosis" group may be receiving treatment for other drugs, such as methamphetamine and cocaine.

Discussion {#section7-2333392817734523}
==========

Despite a growing emphasis on integrating behavioral health and SUD services into medical settings,^[@bibr12-2333392817734523]^ little data exist on the characteristics of individuals who screen positive for SUD in primary care. In the present study, 87% of patients who screened positive for alcohol or opioid misuse in a CHC using the NIDA quick screen had a probable OAUD; of these, only 7% were in treatment for an SUD at the time of the screening. Although this study took place at a single multisite FQHC, our findings suggest that substance misuse screening in CHCs and other primary care settings can tap into a large, unmet need for treatment among primary care patients and that most of the patients who screen positive using this method have a probable disorder. Integrating screening for SUDs into primary care settings is crucial to identifying individuals in need of treatment. The high proportion with a probable disorder as well as those with mental health comorbidities suggest the need for well-defined protocols to ensure referral to an appropriate level of care, either within or outside of the primary care setting, as recommended by the American Society for Addiction Medicine.^[@bibr13-2333392817734523]^ Screening, Brief Intervention, and Referral to Treatment (SBIRT) is one model for identifying and addressing substance misuse, and there is evidence for its effectiveness in reducing risky alcohol consumption.^[@bibr14-2333392817734523]^ However, further research needs to be done to determine whether SBIRT, or other models, is effective for other SUDs.

Patients who screened positive for substance misuse in this study were disproportionately male. National data show men have higher rates of alcohol misuse than women,^[@bibr15-2333392817734523],[@bibr16-2333392817734523]^ and our results align with literature suggesting more men than women screen positive for alcohol misuse in medical settings.^[@bibr17-2333392817734523],[@bibr18-2333392817734523]^ Substance misuse in women is less likely to be identified in health-care settings and more often identified via contact with child protective services.^[@bibr16-2333392817734523]^ It is possible that the women presenting to primary care in our study were less likely to endorse substance use because of stigma or because doing so might put them at risk of child custody problems. It is also possible that in this population, fewer women had substance misuse. Compared to the clinic overall, individuals identified by screening were less likely to identify as Hispanic (29% vs 48%), so it is also possible that the low proportion of women identified with misuse may be related to a lower number of Hispanic women willing to discuss their substance use due to cultural norms and stigma.^[@bibr19-2333392817734523]^ Further study is needed to understand the role of cultural issues, including social norms and stigma around substance use, and low rates of reporting among Hispanic women in primary care settings.

We also found a high prevalence of comorbid mental health disorders among those with substance misuse. Nearly half of those who screened positive reported a diagnosis for bipolar disorder or schizophrenia, and approximately one-quarter of the sample reported that mental health issues currently impede their quality of life. These findings correspond with other studies that show high rates of substance use and mental health comorbidities.^[@bibr20-2333392817734523],[@bibr21-2333392817734523]^ Our results emphasize the importance of CHCs that screen for SUDs being prepared to understand and address both disorders, either through appropriate referral or on-site care.

This study has some limitations. Patients are from a single FQHC, limiting generalizability. The screening and assessment were conducted via face-to-face interviews, which may have led to underreporting of substance use compared with self-administered questionnaires.^[@bibr22-2333392817734523],[@bibr23-2333392817734523]^ Additionally, self-reported mental health diagnosis information was used instead of administrative data because administrative data were only available for those included in the larger study, not for all of those who screened positive for substance misuse. Further, due to limitations in the clinic's administrative database, we were unable to compare the fully clinic population to the study sample on certain patient characteristics.

Nevertheless, findings from this study provide a snapshot of the demographic and mental health characteristics of individuals who present to an urban FQHC with substance misuse. Given the high levels of unmet need for treatment found in epidemiologic studies, our findings suggest that primary care could be an important and underutilized resource for addressing unmet need. Further research is needed to determine how to integrate OAUD screening and treatment into primary care.
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